Return to Publications
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.

Return to Publications  |  Return to CINJ Home
Rutgers Cancer Institute of New Jersey's Cancer Connection, August 2014
Donate NowThe latest news on research, treatment, prevention and education from the
state's only National Cancer Institute-designated Comprehensive Cancer Center
Survival Benefit Lacking for Older Prostate Patients Treated with
Hormone Therapy



Research from Rutgers Cancer Institute of New Jersey shows a common prostate cancer treatment that disables male hormones known to promote growth of prostate cancer lacks survival benefit for older men with localized disease. The study, led by Cancer Institute epidemiologist Grace Lu-Yao, PhD, MPH, professor of medicine at Rutgers Robert Wood Johnson Medical School, focuses on androgen deprivation therapy, which for the past 15 years has become a common alternative to surgery, radiation or conservative management when used as the only therapy.Learn more

Rutgers Cancer Institute of New Jersey Director Honored for Oncology Accomplishments



Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, has been selected to receive the Melvyn H. Motolinsky Research Foundation Distinguished Service Award in recognition of his accomplishments in the field of oncology. Dr. DiPaola, who has international expertise as a prostate cancer physician and researcher, was viewed as a "luminary" in being chosen for this year's honor, which is reserved for those who make a difference in the lives of many through leadership in healthcare, public health, public service or science.Learn more

$600K Gift Fuels Unique Clinical Trial Initiative



The method of treating cancer patients who have genomic abnormalities with drugs designed specifically to target those abnormalities has resulted in higher response rates than have been previously seen. Often times these discoveries are made as part of a clinical trial. Innovation of clinical trial design and the need to assess and streamline established processes for developing and executing these clinical research studies is more important than ever before. A $600,000 gift from Jewels of Charity is fueling a comprehensive clinical trial initiative at Rutgers Cancer Institute of New Jersey that will address those needs.Learn more

Cancer Prevention and the Benefits of Being the 'Garden' State



Did you know that a few simple steps towards cancer prevention can start with a trip to your local farmer's market? Kristin Waldron, RD, CSO, a clinical dietitian at Rutgers Cancer Institute of New Jersey explains the benefits of seasonal fruits and vegetables.Learn more

            Rutgers Cancer Institute of New Jersey                                          NCI logo 

Office of Communications         ·        ·        732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List